162 related articles for article (PubMed ID: 36203529)
1. Comprehensive Analysis of the Molecular Characteristics and Prognosis value of AT II-associated Genes in Non-small Cell Lung Cancer.
Ren L; Wen X; Liu M; Xiao Y; Leng P; Luo H; Tao P; Xie L
Comput Math Methods Med; 2022; 2022():3106688. PubMed ID: 36203529
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
3. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Zhou M; Chen Y; Gu X; Wang C
Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
[No Abstract] [Full Text] [Related]
5. The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling.
Lindskog C; Fagerberg L; Hallström B; Edlund K; Hellwig B; Rahnenführer J; Kampf C; Uhlén M; Pontén F; Micke P
FASEB J; 2014 Dec; 28(12):5184-96. PubMed ID: 25169055
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer.
Cai X; Lin L; Zhang Q; Wu W; Su A
J Int Med Res; 2020 Jun; 48(6):300060520929167. PubMed ID: 32527185
[TBL] [Abstract][Full Text] [Related]
7. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of annexin II expression in human non-small cell lung cancer.
Jia JW; Li KL; Wu JX; Guo SL
Tumour Biol; 2013 Jun; 34(3):1767-71. PubMed ID: 23494179
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
Li J; Zhang Y; Hu D; Gong T; Xu R; Gao J
Aging (Albany NY); 2020 Jul; 12(14):14271-14284. PubMed ID: 32668412
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
13. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.
Drzewiecka H; Jarmołowska-Jurczyszyn D; Kluk A; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582
[TBL] [Abstract][Full Text] [Related]
15. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
17. Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment.
Song L; Wang X; Cheng W; Wu Y; Liu M; Liu R; Zhang S; Xia H; Liu H; Tai X; Zhao H; Li X; Ji F
BMC Pulm Med; 2021 Dec; 21(1):420. PubMed ID: 34923982
[TBL] [Abstract][Full Text] [Related]
18. Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).
Kotoula V; Krikelis D; Karavasilis V; Koletsa T; Eleftheraki AG; Televantou D; Christodoulou C; Dimoudis S; Korantzis I; Pectasides D; Syrigos KN; Kosmidis PA; Fountzilas G
BMC Cancer; 2012 Aug; 12():342. PubMed ID: 22866924
[TBL] [Abstract][Full Text] [Related]
19. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
